Mock-ups checklist - Guidance for checking mock-ups
|
|
- Dominic Nigel McDonald
- 6 years ago
- Views:
Transcription
1 24 March 2014 EMA/102667/2014 Veterinary Medicines Division Mock-ups checklist - Guidance for checking mock-ups This guidance should be read in conjunction with: the guideline on the packaging information of veterinary medicinal s authorised by the Community in Volume 6C as published on the Commission website the Quality Review of Documents veterinary -information annotated template (English) - clean (currently in use template) Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal s as amended Please note that all elements on the approved information (PI) attached to the CVMP opinion should be taken into account when preparing mock-ups. The checks mentioned in this guidance are standard checks and instructions but it remains the approved PI which prevails. 7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0) Facsimile +44 (0) info@ema.europa.eu Website An agency of the European Union
2 READABILITY A. OUTER/IMMEDIATE PACKAGE Comments Critical labelling elements (Invented) name of the veterinary medicinal Strength (if applicable) Pharmaceutical form (only shown on outer pack (Art 58.2)) Active substance(s) Package size(only shown on outer pack (Art 58.2)) Target species Withdrawal period (if applicable) Method and route of administration Indications (if space allows and only where mentioned in the approved PI) Special warnings, if necessary Expression of expiry date, including necessary space for putting appropriate data Special storage conditions, if applicable Special precautions for the disposal of unused s or waste materials, if any The words For animal treatment only and conditions or restrictions regarding supply and use, if applicable Name and address of the MAH Marketing authorisation number Expression of manufacturing batch number, including necessary space for putting appropriate date The words Keep out of the sight and reach of children Nothing obviously promotional. A discreet logo of the MAH can be used. The elements mentioned in bold should be prominent on the packaging, e.g. in larger font size, and it is recommended to mention them on the front of the packaging. This requirement is optional for multilingual packs. Name of the The name should be stated as per the SPC. See example: Vet 0.5 mg tablets for dogs. Format of the name can differ from the format used in the PI. Page 2/8
3 Print size, quality and type Minimum 8 pt. The text should be easily readable (print type, size and space between lines) for the healthcare professionals, farmers or animal owners. The (invented) name of the (e.g. Vet) may be larger than the rest of the text. The rest of the name (e.g. 0.5 mg tablets for dogs) should be located next to or under the (invented) name and can be displayed in a smaller font size. Print colour Distinguishable colours from the background for print of characters should be used. Use of background colour should not adversely impact on readability of the text. Do not use green on red or red on green, as these pose problems for people who are colour blind. Blue-box Please check that the blue-box is present if applicable. Local representative names and/or contact details to be mentioned only if stated in the package leaflet AND in the approved PI. A discreet logo of the local representative is allowed in the blue-box. A blue-box is permitted on the immediate label where there is no outer package. Pictograms/Logo A pictogram in addition to the text is allowed if it is of an informative/educational nature, e.g. for route of administration or species for which the presentation is intended. It is recommended in the case of pictograms displaying animal species, that when feasible, the pictogram be in accordance with the intended presentation (e.g. symbols showing a large dog or a small dog). Pictures / photos of the target species are also allowed on the labelling but should not impact readability of the text. Layout of text Multilingual packs should be clearly legible and, where practical, grouping of text elements for each language is recommended. The use of language abbreviation may also be used to distinguish grouped languages. Page 3/8
4 Barcode A barcode is allowed on the labelling. QR (Quick response) code The applicant/mah should contact the Agency for further information. B. SMALL IMMEDIATE PACKAGING UNITS Comments Critical labelling elements (Invented) name of the veterinary medicinal Strength (if applicable) Pharmaceutical form (only shown on outer pack (Art 58.2)) Quantity of the active substance (if not already included in the name) Package size (only shown on outer pack (Art 58.2) Target species (if not already included in the name) pictogram to be used on a case-by-case basis to replace mentioning the target species) Withdrawal period (if applicable) Route(s) of administration Total content/volume/dose (where relevant) Expression of manufacturing batch number (Batch/Lot) (according to country requirements), including necessary space for putting appropriate data Expression of expiry date (EXP) (according to country requirements), including necessary space for putting appropriate date The words For animal treatment only Nothing obviously promotional. A discreet logo of the MAH can be used. The bold elements to be in larger font size, where feasible. Name of the The name should be stated as per the SPC See example: Vet 0.5 mg tablets for dogs. Format of the name can differ from the format used in the PI. Page 4/8
5 Print size, quality and type Minimum 8 pt. With regard to multi-lingual packaging and very small bottles/vial sizes, e.g. 2 or 10 ml, 8 pt. is in most cases not achievable, but the closest font size should be sought. The text should be easily readable (print type, size and space between lines) for the healthcare professionals, farmers or animal owners. The (invented) name of should be larger than the remainder of the text where feasible. Print colour Distinguishable colours from the background for print of characters should be used. Use of background colour should not adversely impact on readability of the text. Do not use green on red or red on green, as these pose problems for people who are colour blind. Layout of text Multilingual packs should be clearly legible and where practical, grouping of text elements for each language may be done. Blue-box No blue-box should be present, unless specific national requirements are required. Barcode A barcode is allowed on the labelling. QR (Quick response) code The applicant/mah should contact the Agency for further information. Page 5/8
6 C. BLISTER OR STRIP Comments Critical labelling elements (Invented) name of the veterinary medicinal Strength (if applicable) Pharmaceutical form only shown on outer pack (Art 58.2) Active substance(s) Target species (if not already included in the name; clear pictogram might be used on a case by case basis to replace mentioning the target species) Full or abbreviated name of the MAH Expression of expiry date (EXP) (according to country requirements), including necessary space for putting appropriate data Expression of manufacturing batch number (Batch/Lot)(according to country requirements), including necessary space for putting appropriate date The words For animal treatment only. Nothing obviously promotional. A logo of the MAH can be used. A clear pictogram of the target species might be used to replace mentioning the target species. Print size, quality and type Minimum 8 pt. With regard to multi-lingual blisters, 8 pt is in most cases not achievable, but the closest font size should be sought. The text should be easily readable (print type, size and space between lines) for the healthcare professionals, farmers or animal owners. The (invented) name of the (e.g. Vet) should be larger than the rest of the text. Print colour Distinguishable colours from the background for print of characters should be used. Layout of text Where practical, the name and strength of the should appear over each blister pocket. Often it will not be possible to apply all the information over each blister pocket, consequently where a random display of the information is proposed it should frequently appear across the pack. In all cases it will be acceptable to apply the batch number and expiry date to the end of the blister or strip. For blisters with an individual pocket for a single dose, all text must appear on each pocket. Multilingual packs should be clearly legible and where practical, grouping of text elements for each language may be done. Blue-box No blue-box should be present. Page 6/8
7 Barcode / QR (Quick response) code Barcode / QR codes are not allowed on the blister or strip. Only identification barcodes used for identification purpose on the packaging line are allowed. D. PACKAGE LEAFLET Comments Critical elements Nothing obviously promotional. A logo of the MAH can be used. It is advisable that all elements should follow the order of Annex III.B of the current QRD template and the approved package leaflet. Name of the The name should be stated as per the SPC; See example: Vet 0.5 mg tablets for dogs. In case of multilingual package leaflets the information above should appear at the beginning of each language. The use of language abbreviations may also be used to distinguish multilingual package leaflets. Print size, quality and type Minimum 8 pt. The text should be easily readable (print type, size and space between lines) for the healthcare professionals, farmers or animal owners. The readability should be acceptable e.g. font size, layout and paper quality. The pictures explaining the use of the medicinal should be clearly printed. Print colour Distinguishable colours from the background for print of characters should be used. Page 7/8
8 Local representatives Listing of local representatives is not a requirement, but if included in the information annexes, the full list for all Member States must be stated. However, a representative may be designated for more than one country and may also be the MAH where no other local representative is indicated. In cases where the same representative is designated for more than one country, the representative s details may be listed only once below the names of the countries concerned. In the printed package leaflet, only the concerned local representative can be mentioned provided the whole list has been included in the information annexes. Blue-box No blue-box is required. QR (Quick response) code The applicant/mah should contact the Agency for further information. Page 8/8
SmPC and. & New QRD. Spanish Medicines Agency (AEMPS)
SmPC and Labelling User Testing & New QRD template Blanca García-Ochoa Martín Spanish Medicines Agency (AEMPS) Legal framework Directive 2001/83/EC of the European Parliament and of the Council of 6 November
More informationEMA procedural updates
EMA procedural updates Regulatory noticeboard EMA Veterinary Medicines Info Day 16-17 March 2017, London Presented by Emily Drury on 17 March 2017 Scientific Administrator (Project Manager), Veterinary
More informationUser guide on how to generate PDF versions of the product information - veterinary
03 February 2011 EMA/793983/2010 v.1.0 Patient Health Protection User guide on how to generate PDF versions of the product information - veterinary Introduction Since the product information consists of
More informationStandard operating procedure
Standard operating procedure Title: Checking of mock-ups and specimens for new applications and extensions Status: PUBLIC Document.: SOP/H/3013 Lead author Approver Effective date: 17-DEC-10 Name: Ana
More informationStandard operating procedure
Standard operating procedure Title: of medicinal products Status: PUBLIC Document no.: SOP/INSP/2000 Lead author Approver Effective date: 03-APR-12 Name: Camelia Manta Name: Fergus Sweeney Review date:
More informationPackaging and labelling
QRDvet template, opportunities for reduced label text and multi-lingual labels, recent examples EMA/IFAH-Europe Info Day 2014 Presented by: Jóhann M. Lenharðsson CVMP member (IS) An agency of the European
More informationEXEMPTIONS: PROCEDURE TO BE FOLLOWED FOR MEDICINES FOR HUMAN USE
EXEMPTIONS: PROCEDURE TO BE FOLLOWED FOR MEDICINES FOR HUMAN USE Table OF CONTENTS Introduction... 2 Category 1. Deviations from the primary and secondary (harmonised) packaging for which an exemption
More informationThis is the production release of the second iteration of EudraCT 8.1. It includes the following main functional changes:
9 September 2011 EMA/646917/2011 Release notes EudraCT Version: 8.1.1 Goal: Release 8.1 Iteration 2 Release Date: 12/09/11 Environment: Production (Public) Release Contents: This is the production release
More informationGUIDELINE ON THE READABILITY OF THE LABELLING AND PACKAGE LEAFLET OF MEDICINAL PRODUCTS FOR HUMAN USE Revision 1, 12 January 2009
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 12.1.2009 ENTR/F/2/SF/jr (2009)D/869 GUIDELINE ON THE READABILITY OF THE LABELLING AND PACKAGE LEAFLET
More informationStandard operating procedure
Standard operating procedure Title: Translation of product information for SME applicants of the centralised procedure Status: PUBLIC Document no.: SOP/EMA/0100 Lead author Approver Effective date: 28-JUN-10
More informationLead Author Approver Effective Date: 13-MAR-13 Name: Ana Rodriguez Sanchez Review Date: 13-MAR-16
Work instructions Title: Data entry in Corporate GxP for GCP and PhV inspections Applies to: P-CI-CNC Status: PUBLIC Document no.: WIN/INS/2050 Lead Author Approver Effective Date: 13-MAR-13 Name: Maria
More informationStandard operating procedure
Standard operating procedure Title: Sampling and testing of centrally authorised products Reports circulation and follow-up procedure Status: PUBLIC Document.: SOP/INSP/2011 Lead author Approver Effective
More informationDRAFT GUIDELINE ON THE READABILITY OF THE LABEL AND PACKAGE LEAFLET OF MEDICINAL PRODUCTS FOR HUMAN USE Revision September 2006
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Brussels, September 2006 DRAFT GUIDELINE ON THE READABILITY OF THE LABEL AND PACKAGE LEAFLET OF MEDICINAL PRODUCTS FOR HUMAN USE Revision
More informationGuidance for the format and content of the final study report of non-interventional post-authorisation safety studies
23 January 2013 EMA/48663/2013 Patient Health Protection Guidance for the format and content of the final study report of non-interventional post-authorisation safety studies Introduction From 10 January
More informationAll external requests for access to information as well as their responses are entered into the Queries database.
Work instructions Title: Documentation of external requests for access to information (from healthcare professionals, patients and the general public) and their responses Applies to: Staff in the Medical
More informationStandard operating procedure
Standard operating procedure Title: Handling of financial procedure for parallel distribution Status: PUBLIC Document.: SOP/INSP/2013 Lead author Approver Effective date: 11-OCT-11 Name: Camelia Manta
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) GUIDELINE ON REQUIREMENTS FOR PLASMA MASTER FILE (PMF) CERTIFICATION
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 26 February 2004 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) GUIDELINE ON REQUIREMENTS
More informationSUBMISSION OF COMMENTS ON Guideline on Real Time Release Testing (formerly Guideline on Parametric Release) Draft
26 August 2010 European Medicines Agency 7 Westferry Circus Canary Wharf London E14 4HB United Kingdon Attn: Quality Working Party SUBMISSION OF COMMENTS ON Guideline on Real Time Release Testing (formerly
More informationStandard operating procedure
Standard operating procedure Title: Handling of external requests on EU-CTR and EudraCT Status: PUBLIC Document no.: SOP/INSP/2044 Lead author Approver Effective date: 04-SEP-12 Name: Raffaella Chersoni
More informationTitle: Handling of Art. 29(1) referrals to the CMDh (60 day procedure) by the CMDh secretariat (incl. Article 13 referrals for variations)
Work instructions Title: Handling of Art. 29(1) referrals to the CMDh (60 day procedure) by the CMDh secretariat (incl. Article 13 referrals for variations) Applies to: CMDh secretariat within the Scientific
More informationPre-notification check for type IB Variations 1
Pre-notification check for type IB Variations 1 This pre-notification checklist is aimed at facilitating submission of complete and correct Type IB variation notifications by Marketing Authorisation Holders
More informationGuide to Labels and Leaflets of Human Medicines
Guide to Labels and Leaflets of Human Medicines AUT-G0034-18 08 NOVEMBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS 1
More informationLiiV Handbook. Version 2.1. Supplier information in the VARA register. This handbook describes pharmaceutical companies work in LiiV
LiiV Handbook Supplier information in the VARA register Version 2.1 This handbook describes pharmaceutical companies work in LiiV Contents 1. Introduction... 4 1.1 Information owner... 4 2. How does LiiV
More informationWork instructions. 1. Changes since last revision. 2. Records. 3. Instructions. Documents needed for this WIN
Work instructions Title: Announcement of Good Clinical Practice/Pharmacovigilance inspection to reporting inspectorate, applicant and 3 rd country inspectorate prepared by P-CI-CNC Applies to: Clinical
More informationeaf Release Notes Table of Contents Version (Release Date: 13/07/2018)... 7 Version (Release Date: 16/02/2018)...
13 th July 2018 Information Technology EMA/470951/2018 This document lists and briefly describes the new features and fixed issues included in the release of the electronic application form: Application
More informationStandard operating procedure
Standard operating procedure Title: Procedure for liaising between the EMA, the CHMP and the CTFG on the potential CHMP negative opinion, pre-opinion or post-authorisation withdrawal, suspension or revocation
More informationBEST PRACTICE GUIDE for Type IB Variations. CMD(v)/BPG/005. Edition 00. Edition date: Implementation date:
Co-ordination Group for Mutual Recognition and Decentralised Procedures - Veterinary EMEA/CMD(v)/115405/2005 BEST PRACTICE GUIDE for Type IB Variations Edition 00 Edition date: 10-12-2005 Implementation
More informationBrand Guidelines XDS (External Development Summit)
Brand Guidelines XDS (External Development Summit) Brand Guidelines XDS (External Development Summit) About XDS (External Development Summit) is the first professionals-only video games industry event
More informationNews from Fimea Johanna Linnolahti Fimea
News from Fimea 16.11.2017 Johanna Linnolahti Fimea Near future Fimea to be well-equipped for future challenges (e.g. Brexit) new organisation started 1.1.2018 Business as usual, but responding to possible
More informationCover note on XEVMPD substance controlled vocabulary following the quality control exercise
5 April 2018 EMA/93253/2014, Rev. 1 1 Information Management Cover note on XEVMPD substance controlled vocabulary following the quality control 1 MDMS contact point was replaced by EMA Service Desk. 30
More informationStandard operating procedure
Standard operating procedure Title: Processing of type II variations for medicinal products for veterinary use Status: PUBLIC Document no.: SOP/V/4004 Lead author Approver Effective date: 10-DEC-15 Name:
More informationChapter 5: Extended EudraVigilance Product Report Acknowledgement Message
4 April 2014 EMA/718844/2011 Patient Health Protection Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European
More informationThe WIN applies to the Vet Applications team in the Veterinary Regulatory and Organisational Support service (V-VM-ROS).
Work instructions Title: Handling of Veterinary e-submissions Applies to: Veterinary applications team Status: PUBLIC Document no.: WIN/V/4062 Lead Author Approver Effective Date: 18-JUL-16 Name: Dorota
More informationMANUAL OF SUBMISSION OF APPLICATIONS FOR CERTIFICATES OF A PHARMACEUTICAL PRODUCT WHO MODEL AND STATEMENTS OF PHARMACEUTICAL PRODUCTS
MANUAL OF SUBMISSION OF APPLICATIONS FOR CERTIFICATES OF A PHARMACEUTICAL PRODUCT WHO MODEL AND STATEMENTS OF PHARMACEUTICAL PRODUCTS GLOSSARY... 2 INTRDUCTION... 3 Objective... 3 DEFINITIONS... 3 Certificate
More informationStandard operating procedure
Standard operating procedure Title: Notifications from MAHs on PhV non-compliance issues Status: PUBLIC Document no.: SOP/INS/2061 Lead author Approver Effective date: 11-APR-17 Name: Camelia Mihaescu
More informationBetter Training for Safer Food initiative. Visual identity. guidelines for Contractors. Executive Agency for Health and Consumers
Better Training for Safer Food initiative Visual identity guidelines for Contractors Executive Agency for Health and Consumers Visual Identity Guidelines for Contractors Of the European Commission s Initiative
More informationIRIS Quick guide to the portal for Orphan Industry users
28 June 2018 EMA/444925/2018 Information Management Division IRIS Quick guide to the portal for Orphan Industry users Version 1.3 1. Purpose and context... 2 1.1. Purpose of this Quick Guide... 2 1.2.
More informationManagement of RMP for CAPs in postauthorisation
Management of RMP for CAPs in postauthorisation EMA perspective Presented by Iordanis Gravanis on 9 November 2015 Head of Evaluation Procedures C, Procedure Management (and Committees Support) An agency
More informationeaf Release notes Table of Contents Version (Release Date: 28/09/2018)... 7 Version (Release Date: 13/07/2018)...
28 th September 2018 Information Technology EMA/662543/2018 This document lists and briefly describes the new features and fixed issues included in the release of the electronic application form: Application
More informationHow to send submissions via the Web Client
September 2017 EMA/737304/2012 How to send submissions via the Web Client Guidance for applicants 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44
More informationeaf Release Notes The most recent release appears first. Table of Contents Version (Release Date: 04/02/2019)... 7
February 2019 Information Technology EMA/912291/2019 This document lists and briefly describes the new features and fixed issues included in the release of the electronic application form: Notice to Applicants
More informationBEST PRACTICE GUIDE. For Type IB Variations. CMDv/BPG/005 Edition 05. Edition date: 10 April 2015
EMA/CMDv/115405/2006 BEST PRACTICE GUIDE Edition 05 Edition date: 10 April 2015 Implementation date: 10 April 2015 Page 2 of 10 Index 1. Introduction 2. Aim and Scope 3. Reference documents and/or related
More informationGuidance for submission and validation of electronic declaration of interests and electronic curriculum vitae
30 March 2017 EMA/676053/2014 Rev. 1 Guidance for submission and validation of electronic declaration of interests and Table of Contents 1. Scope... 2 2. Electronic declaration of interests form... 2 2.1.
More informationAll the documents related to the EU-RMP Annex 1 activities are stored at the following locations:
Work instructions Title: EU-RMP annex 1: validation Applies to: Risk Management Section Status: PUBLIC Document no.: WIN/H/3292 Lead Author Approver Effective Date: 04-FEB-11 Name: Daniel Becker Name:
More informationStandard operating procedure
Standard operating procedure Title: Handling of requests for information Status: PUBLIC Document no.: SOP/EMA/0019 Lead author Approver Effective date: 24-JUL-15 Name: Marketa Liskova Name: Andreas Pott
More informationPMS Iteration 1: analysis of the data efforts & value results and recommendation on the scope
PMS Iteration 1: analysis of the data efforts & value results and recommendation on the scope EU ISO IDMP Task Force 19 February 2016 Presented by Ilaria Del Seppia Data Standardisation and Analytics,
More informationextended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step Guide
extended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step Insert of a Development Medicinal Product (DMP) 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44
More informationeaf Release notes Table of Contents Version (Release Date: 16/02/2018)... 7 Version (Release Date: 15/12/2017)...
16 th February 2018 Information Technology EMA/94046/2018 This document lists and briefly describes the new features and fixed issues included in the release of the electronic application form: Application
More informationCMD(v)/BPG/006. BEST PRACTICE GUIDE For. Type II Variations. Edition 00. Edition date:
Co-ordination Group for Mutual Recognition and Decentralised Procedures - Veterinary EMEA/CMD(v)/115377/2006 BEST PRACTICE GUIDE For Type II Variations Edition 00 Edition date: 19-01-2006 Implementation
More informationGuideline on the specifications for provision of an electronic submission (e-submission) for a veterinary medicinal product
Guideline prepared by the TIGes-Vet Version 1.0 June 2009 Guideline on the specifications for provision of an electronic submission (e-submission) for a veterinary medicinal product 1. Introduction This
More informationeaf Release notes Table of Contents Version (Release Date: 13/07/2018)... 7 Version (Release Date: 16/02/2018)...
13 th July 2018 Information Technology EMA/470952/2018 This document lists and briefly describes the new features and fixed issues included in the release of the electronic application form: Application
More informationGuidance for registration with EudraVigilance Veterinary
11 July 2014 Veterinary Medicines and Product Data Management Table of Contents 1. Summary.2 2. Overview of the registration process 3 3. General information you should familiarise yourself with before
More informationesubmissions Web UI Release Notes
23 June 2017 EMA/507917/2016 Release Notes This document lists and briefly describes the new features and fixed issues included in the release of the web UI component. The most recent release appears first.
More informationVisual Identity Manual
Visual Identity Manual 2015 v1 February 2015 Visual Identity Manual - 2015 Table of Contents Introduction... 1 European Youth Week 2015visual identity... 2 Verbal branding... 2 Colour... 3 Size and shape...
More informationApplies to: SA Administrative Assistant, SAWP Scientific Secretary and SA secretarial team in Scientific Advice Section
Work instructions Title: Use of scientific advice and protocol assistance database Applies to: SA Administrative Assistant, SAWP Scientific Secretary and SA secretarial team in Scientific Advice Section
More informationThere are two basic designs of the new logo. They are professionally developed graphic files and the use of them must be strictly controlled.
LOGO There are two basic designs of the new logo. They are professionally developed graphic files and the use of them must be strictly controlled. If a Chapter wishes to develop promotional materials or
More informationUser Guidance for submissions via esubmission Gateway / Web Client using xml delivery files
29 September 2017 EMA/346582/2016 User Guidance for submissions via esubmission Gateway / Web Client using xml delivery files 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44
More informationSubmission of information in the public consultation on potential candidates for substitution under the Biocidal Products Regulation
Submission of information in the public consultation on potential candidates for substitution under the Biocidal Products Regulation Version 3.0 May 2017 2 Submission of information in the public consultation
More informationMultinational assessment teams
14 July 2017 EMA/486654/2016 Deputy Executive Director Guide for rapporteurs and coordinators 1. Background The multinational assessment team (MNAT) concept allows the option of an assessment team to be
More informationesubmissions Web UI Release Notes
28 September 2017 EMA/507917/2016 Release Notes This document lists and briefly describes the new features and fixed issues included in the release of the web UI component. The most recent release appears
More informationPSUR Repository and the EU single assessment
PSUR Repository and the EU single assessment 3 rd industry stakeholder platform - operation of EU pharmacovigilance legislation Presented by Irene Rager on 13 March 2015 Head of Service E Procedure Management
More informationOn-boarding of users to SPOR data services
02 October 2018 version 2 EMA/307181/2017 Information Management Division 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5550 Send
More informationeaf Release Notes The most recent release appears first. Table of Contents Version (Release Date: 13/07/2018)... 7
13 th July 2018 Information Technology EMA/470949/2018 This document lists and briefly describes the new features and fixed issues included in the release of the electronic application form: Notice to
More informationICH Topic M 4 Common Technical Document for the Registration of Pharmaceuticals for Human Use Organisation CTD. Step 5
European Medicines Agency February 2004 CPMP/ICH/2887/99 ICH Topic M 4 Common Technical Document for the Registration of Pharmaceuticals for Human Use Organisation CTD Step 5 COMMON TECHNICAL DOCUMENT
More informationEMA esubmission Gateway and Web Client: Questions and answers on Veterinary Applications
March 2014 EMA/143202/2014 EMA esubmission Gateway and Web Client: Questions and answers on Veterinary Applications This question and answer document aims to address the commonly-asked questions and provide
More information3 September
3 September 2012 Reference: EMA 12007 By e-mail: Silvia.Domingo@ema.europa.eu Dr. Silvia DOMINGO European Medicines Agency 7 Westferry Circus Canary Wharf London E14 4HB, United Kingdom Subject: epmf Database
More informationeaf Release Notes The most recent release appears first. Table of Contents Version (Release Date: 28/09/2018)... 7
28 th September 2018 Information Technology EMA/662540/2018 This document lists and briefly describes the new features and fixed issues included in the release of the electronic application form: Notice
More informationesubmission Gateway and Web Client Training on the use of XML delivery files for Veterinary submissions
esubmission Gateway and Web Client Training on the use of XML delivery files for Veterinary submissions Webinar training on v1.0 Presented by Kristiina Puusaari on 3 June 2016 An agency of the European
More informationDate: May 19, Dear Dr. Domingo,
Date: May 19, 2015 Reference: EMA15003 VIA E-MAIL Dr. Silvia Domingo European Medicines Agency 30 Churchill Place, Canary Wharf London E14 5EU UNITED KINGDOM Silvia.Domingo@ema.europa.eu Dear Dr. Domingo,
More informationWASH Cluster Style Guide V1 - June GWC Style Guide 2016.indd 1 28/06/16 11:32
WASH Cluster Style Guide V1 - June 2016 GWC Style Guide 2016.indd 1 28/06/16 11:32 WASH Cluster Style Guide - General Guidelines General guidelines The objective of this style guide is to ensure that documents
More informationList of nationally authorised medicinal products
27 January 2016 EMA/194278/2016 Procedure Management and Committees Support Active substance: Gadoteric acid (IV and intravascular formulations) Procedure no.: PSUSA/00001506/201504 30 Churchill Place
More informationComments received from public consultation on good pharmacovigilance practices (GVP)
25 June 2012 EMA/428915/2012 Patient Health Protection Comments received from public consultation on good pharmacovigilance practices (GVP) GVP Module VII Periodic safety update report The first seven
More informationCREATING A SAFETY MESSAGE STEP-BY-STEP GUIDE
CREATING A SAFETY MESSAGE STEP-BY-STEP GUIDE This step by step describes the process of creating an ADR initial report. The information in the fictitious European Veterinary Pharmacovigilance Reporting
More informationEUROPEAN MEDICINES AGENCY (EMA) CONSULTATION
EUROPEAN MEDICINES AGENCY (EMA) CONSULTATION Guideline on GCP compliance in relation to trial master file (paper and/or electronic) for content, management, archiving, audit and inspection of clinical
More informationextended EudraVigilance Medicinal Product Dictionary (XEVMPD) Step-by-Step Guide
5 April 2018 EMA/524417/2014 Information Management extended EudraVigilance Medicinal Product Dictionary (XEVMPD) Step-by-Step Guide Insert of a Pharmacovigilance System Master File Location (MFL) entity
More informationBEST PRACTICE GUIDE for The classification of unforeseen variations
EMA/CMDv/499821/2008 CMDv/BPG/015 BEST PRACTICE GUIDE for The classification of unforeseen variations Edition number: 02 Edition date: 18 December 2012 Implementation date: 18 December 2012 1 1 Amending
More informationEudraVigilance Release Notes v.1.13
24 April 2018 EMA/253902/2018 Information Management 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website
More informationMeasures for Article 57 Data Quality Assurance
14 October 2015 EMA/465609/2015 Inspections and Human Medicines Pharmacovigilance Measures for Article 57 Data Quality Assurance 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationEudraVigilance Components & Functionality Introduction
EudraVigilance Components & Functionality Introduction Training Module EV-M2 This module outlines the EudraVigilance system components and system functionalities An agency of the European Union Content
More informationENCePP Code of Conduct Implementation Guidance for Sharing of ENCePP Study Data
EMA/409316/2010 Revision 2, dated 14 July 2016 European Network of Centres for Pharmacoepidemiology and Pharmacovigilance ENCePP Code of Conduct Implementation Guidance for Sharing of ENCePP Study Data
More informationECC Style Guide. ECC Style Guide
ECC Style Guide ECC Style Guide 23 November 2011 Page 2 0 EXECUTIVE SUMMARY This document provides guidance to introduce consistency across all Electronic Communications Committee (ECC) communications
More informationSubmissions to the PSUR Repository using EMA Gateway/Web Client
Submissions to the PSUR Repository using EMA Gateway/Web Client Webinar training to existing Gateway users Presented by Kristiina Puusaari on 10 February 2015 An agency of the European Union Presenters
More informationSeptember 2015 Ginas Meeting Highlights
September 2015 Ginas Meeting Highlights European Network Data Board Meeting 24 Sep 2015 ISO IDMP EU Taskforce 25 Sep 2015 An agency of the European Union The meeting was divided in two main sessions: Public
More informationProcess description for managing duplicates in the context of the Medical Literature Monitoring (MLM) service
9 June 2015 EMA/262834/2015 Information Management Division Process description for managing duplicates in the context of the Medical Literature Monitoring (MLM) In support of the monitoring of medical
More informationextended EudraVigilance Medicinal Product Dictionary (XEVMPD) e-learning
extended EudraVigilance Medicinal Product Dictionary (XEVMPD) e-learning Session 3: Database Architecture Version 5.3 An agency of the European Union Roles of the XEVMPD in the EV System (1) The roles
More informationelectronic Application Form Data Exchange Standard 3.0
ELECTRONIC APPLICATION FORM electronic Application Form Data Exchange Standard 3.0 Supplementary Specification Annex 3 Application for Renewal of Marketing Authorisation (Merged Version) 7.6, CURRENT 1
More informationPolicy on the Standardisation of Documentation
Policy on the Standardisation of Documentation Policy Number Target Audience Approving Committee IMTD001 CCG Board members and staff CCG Executive Date Approved November 2013 Last Review Date July 2016
More informationIRIS Quick guide to registration
21 June 2018 EMA/416538/2018 Information Management Division IRIS Quick guide to registration Version 1.2 1. Purpose and context... 2 1.1. Purpose of this Quick Guide... 2 1.2. Context... 2 2. How to know
More informationQ&A QP Declaration. Table of contents
CMDh/340/2015/Rev.5 December 2018 Table of contents 1. Why can an audit performed by a European National Health Authority not be used in order to support a QP Declaration? /Why is an on-site audit performed
More informationFirefighters Pensions (England) Scheme Advisory Board Paper 2. SAB communication and branding guidelines
Meeting of the Board 1 December 2017 ITEM 10 SAB communication and branding guidelines Purpose of report For decision. Background 1. A paper was presented to the Board for comment at the meeting of 30
More informationBiocides Submission Manual
MANUAL Biocides Submission Manual Technical guide: using R4BP 3 - 2 Biocides Submission Manual Version 7.0 BSM Technical guide: using R4BP 3 Reference: ECHA-14-B-07-EN Catalogue number: ISBN: DOI: Publ.
More informationSymbol and Wordmark. Symbol. Wordmark
Symbol and Wordmark Symbol Wordmark The Symbol was developed with KCPC s vision and mission in mind. A simple, clean, and dynamic image was created using Vision-1-2-3 and Vision BLESSING. Vision-1-2-3
More informationFSS CORPORATE LOGO USAGE/GUIDELINES
FSS CORPORATE LOGO USAGE/GUIDELINES INTRODUCTION Our brand has an impact on almost everything we do. It affects how we present ourselves and how we are perceived by others. These guidelines should be used
More informationConsultation document: Summary of Clinical Trial Results for Laypersons
SANTE-B4-GL-results-laypersons@ec.europa.eu Consultation document: Summary of Clinical Trial Results for Laypersons Professor DK Theo Raynor, University of Leeds d.k.raynor@leeds.ac.uk This is my response
More information3 STEPS TO FINDING A JOB YOUTH GUARANTEE
3 STEPS TO FINDING A JOB YOUTH GUARANTEE Guidelines on how to use the toolkit and visual elements CONTENTS 1. INTRODUCTION...3 1.1. BACKGROUND...3 1.2. HOW TO USE THE TOOLKIT...4 1.3. COPYRIGHT NOTICE...4
More informationGUIDELINES FOR THE USE OF THE SERVICES DIRECTIVE NOTIFICATIONS FUNCTION IN IMI
GUIDELINES FOR THE USE OF THE SERVICES DIRECTIVE NOTIFICATIONS FUNCTION IN IMI 2 Contents I. BACKGROUND... 3 II. NOTIFICATION FLOW - Overview... 3 1) CREATION... 5 2) BROADCAST... 8 3) MODIFICATION after
More informationMac. Logo Guidelines March 2018
Mac Logo Guidelines March 2018 Contents Overview 3 Basics 4 Graphic Standards 5 Using the Mac Logo 6 Avoid Mistakes 7 Legal Requirements 8 2 Overview These guidelines explain the correct use of the Mac
More informationComplementary Medicines. Registration: Process, Format and Requirements
Complementary Medicines Registration: Process, Format and Requirements Feb 2014 Estelle Taute Overview Registration process Dossier format Requirements - Guidelines - Technical Quality, Safety, Efficacy
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL Questions & Answers Implementation of ectd in South Africa This document is intended to provide clarity on guidelines and specifications for applications for the registration
More informationMEDICAL DEVICES REGULATIONS 2002: REGULATIONS 19 and 30 FORM RG2
MEDICAL DEVICES REGULATIONS 2002: REGULATIONS 19 and 30 FORM RG2 REGISTRATION OF PERSONS RESPONSIBLE FOR PLACING DEVICES ON THE MARKET PART 1: About the notification Please read the accompanying guidance
More information